Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.
Press releases published on May 29, 2025

atai Life Sciences to Participate in Upcoming Investor Conferences
NEW YORK and BERLIN, May 29, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, …

Communiqué de presse : L’avantage de Beyfortus pour la santé publique renforcé par la première comparaison en situation réelle des programmes de vaccination infantile et maternelle contre le VRS
L’avantage de Beyfortus pour la santé publique renforcé par la première comparaison en situation réelle des programmes de vaccination infantile et maternelle contre le VRS Des données de dernière minute montrent que les hospitalisations dues au virus …

CRISPR Therapeutics to Participate in Upcoming Investor Conferences
ZUG, Switzerland and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior …

IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
WINTER SPRINGS, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI environments, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance …

Dataiku Named Leader for 4th Consecutive Time in the 2025 Gartner® Magic Quadrant™ for Data Science and Machine Learning Platforms
NEW YORK, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Dataiku, The Universal AI Platform™, today announced that it has once again been recognized as a Leader in the 2025 Gartner Magic Quadrant for Data Science and Machine Learning Platforms. This marks the fourth …

NSF Becomes Preferred Certification Body For Xometry’s Thomasnet® Industrial Sourcing Platform
ANN ARBOR, Mich. and NORTH BETHESDA, Md., May 29, 2025 (GLOBE NEWSWIRE) -- NSF, a recognized global leader in public health and safety certification, today announced that it has become the preferred certification body for Xometry’s Thomasnet®, the digital …

Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders
Dr. Sean Tucker, Founder and CSO of Vaxart, Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 Company Corrects Record on Common Misconceptions Regarding the Reverse Stock Split Proposal SOUTH SAN …

YIKES, A BOLD BETTER-FOR-YOU HOT CHIP, SET TO HIT SHELVES IN JUNE 2025
YIKES WILL HIT THE SHELVES IN JUNE, A BOLD AND BETTER FOR YOU ROLLED TORTILLA CHIP FLAVOR PACKED WITH A VARIETY OF FLAVORS TO CHOOSE FROM MIAMI, FL, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Introducing YIKES: A Bold, Better-For-You Hot Chip Set …

CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, …

Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference
WATERTOWN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

Reflect Scientific Completes $550,000 Next-Generation Freezer Installation for Pharmaceutical Client
OREM, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in ultra-low temperature freezer technology, today announced the successful completion of a major installation project valued at $550,000. The deployment, which …

KALA BIO to Present at Jefferies Global Healthcare Conference
ARLINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today …

Septerna to Present at Jefferies Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., Chief Executive …

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced that …

Synergy CHC Announces Appointment of Erik Shields as Vice President of Beverage
WESTBROOK, Maine, May 29, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that Erik Shields has been named Vice President of Beverage of …

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
WALTHAM, Mass. and BOULDER, Colo., May 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its presentation at the …

Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders
DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced …

Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain
CC-42344 was shown to be highly active against the highly pathogenic 2024 Texas H5N1 avian influenza strain The Company’s virology study further confirmed the previous structural and in vitro data that revealed the binding of CC-42344 to PB2 protein of the …

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune …

Replimune to Present at the 2025 Jefferies Global Healthcare Conference
WOBURN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members of the Replimune management team will …